North America Polysomnography (PSG) Market

The North America polysomnography (PSG) market is estimated to be valued at USD 6,242.6 Mn in 2026 and is expected to reach USD 10,337.5 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 7.5% from 2026 to 2033. Polysomnography (PSG) is a specialized type of diagnostic sleep study that simultaneously measures several physiological parameters. It is considered the ‘gold standard’ for diagnosing sleep disorders like sleep apnea and the associated Obstructive sleep Apnea (OSA), narcolepsy, restless legs syndrome and periodic limb movement disorders and parasomnias, among others. Polysomnography (PSG) uses several monitoring sensors to measure: Brain activities (EEG), eye movements (EOG), muscle activities (EMG), heart rate (ECG), air flow from the nose and mouth, oxygen levels, body posture providing clinicians with detailed data for accurate diagnosis and treatment planning. North America polysomnography (PSG) market is driven by the rising prevalence of sleep disorders, increasing awareness of the health risks associated with untreated sleep conditions, and continuous advancements in sleep monitoring technologies. The market comprises PSG devices, software, accessories, and related services used across hospitals, sleep laboratories, home healthcare settings, and research institutions throughout the U.S. and Canada. Market Dynamics North America polysomnography (PSG) market is primarily driven by the growing prevalence of sleep disorders, an increasing elderly population and an elevated awareness of potential long-term health implications of untreated disorders like obstructive sleep apnea (OSA). Favorable reimbursement policies, growing physician referrals, and advancements in portable and home-based PSG technologies have further improved access to sleep diagnostics and supported market growth across the region. However, the growth of market is limited by factors such as high cost of PSG equipment, significant investment required for accredited sleep laboratories, and a shortage of trained sleep technologists. Nevertheless, there are abundant growth prospects due to factors such as increasing adoption of artificial intelligence (AI)-enabled sleep analysis, expanding use of home sleep testing (HST), and continued innovation in digital sleep diagnostics. Key Features of the Study • This report provides in-depth analysis of the North America polysomnography (PSG) market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the North America polysomnography (PSG) market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Koninklijke Philips N.V., ResMed Inc., Natus Medical Incorporated, Compumedics Limited, Nihon Kohden Corporation, Cadwell Industries, Inc., Nox Medical, SOMNOmedics GmbH, Cleveland Medical Devices Inc., and Itamar Medical Ltd. • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The North America polysomnography (PSG) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the North America polysomnography (PSG) market Market Segmentation • Product and Services Insights (Revenue, USD Mn, 2021 - 2033) o Devices o Accessories o Consumables o Services • End User Insights (Revenue, USD Mn, 2021 - 2033) o Hospitals o Homecare settings o Others • Key Players Insights o Koninklijke Philips N.V. o ResMed Inc. o Natus Medical Incorporated o Compumedics Limited o Nihon Kohden Corporation o Cadwell Industries, Inc. o Nox Medical o SOMNOmedics GmbH o Cleveland Medical Devices Inc. o Itamar Medical Ltd.